DNA DAY™ 2026: GeneAI Forecast within the GeneLife App Upgraded with 15 AI Predictive Models and Enhanced Lifestyle Integration
Genesis Healthcare announced a major update to its GeneAI Forecast, expanding its AI disease predictive models to 15 and enabling direct integration with Apple Health and Google Fit to merge genetic and daily lifestyle data.
📋 Article Processing Timeline
- 📰 Published: April 25, 2026 at 00:10
- 🔍 Collected: April 24, 2026 at 15:32
- 🤖 AI Analyzed: April 24, 2026 at 23:00 (7h 28m after Collected)
Tokyo, Japan - April 24, 2026 - In celebration of DNA DAY™, Genesis Healthcare Co. today announced a major update to its GeneAI Forecast. With this update, the AI-driven risk prediction models have been expanded to 15 types, and integration with real-life lifestyle data has been further strengthened.
It All Starts with DNA Data
GeneAI Forecast is built upon the foundation of DNA data and key biomarkers, forming a health and wellness baseline optimized for each individual. Based on this foundation, the AI continuously refines its risk predictions, evolving beyond static reports into a continuously advancing system that enables earlier and clearer understanding of health risks.
Expanding the Scope of Predictability
In this update, four new predictive models have been added: Irritable Bowel Syndrome (IBS), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Osteoarthritis, and Osteoporosis. These are diseases that often progress gradually with almost no initial symptoms. With a total of 15 models, GeneAI Forecast provides insights for early understanding of potential health risks at a stage where interventions are highly effective.
Integrating Biology and Behavior
GeneAI Forecast has already integrated multiple biomarkers, including key health indicators such as BMI, blood pressure, and blood glucose levels, adding crucial context to DNA data. This update further strengthens the platform's capabilities by capturing real-world behavioral data through integration with Apple Health and Google Fit, directly reflecting activity information like daily step counts into the predictive models. By combining DNA data, biomarkers, and lifestyle information, GeneAI Forecast visualizes personal health risks in a way that continuously evolves over time.
From Prediction to Action
By integrating genetic, biological, and behavioral information, GeneAI Forecast goes beyond mere risk assessment to more clearly indicate the factors influencing an individual's risk profile. This approach helps identify areas for potential intervention, enabling more informed and proactive healthcare decision-making.
Moving Toward a More Proactive Health Model
Michel Mommejat, Representative Director of Genesis Healthcare Co., stated: 'It all starts with DNA data. It is the foundation for understanding personal health and wellness. GeneAI Forecast is built upon this foundation by combining genetic insights, biomarkers, and real-life behavioral data. This allows us to provide more accurate and meaningful predictions, helping individuals discover concrete actions to manage their risks. This is a vital step toward a more proactive, personalized preventive healthcare model.'
To date, Genesis Healthcare has conducted over 2.9 million genetic tests and is building one of the largest genomic datasets in Japan and Asia. GeneAI Forecast represents a shift from static information to continuous, context-based intelligence, supporting long-term, proactive health management.
About Genesis Healthcare Co.
Genesis Healthcare Co. (English company name: A.D.A.M. Innovations Co.) is a pioneer in genomics, AI, and precision health solutions. The company develops cutting-edge technologies across a wide range of genetic fields, including clinical diagnostics, AI-driven R&D data platforms, and consumer genetic testing services. They have conducted over 2.9 million genetic tests and possess the largest R&D genomic database regarding the Japanese population.
About GeneLife
GeneLife is Genesis Healthcare's genetic testing service brand for general consumers. Providing genetic testing services to individuals through at-home test kits and e-commerce channels, it helps people achieve better lives and longevity through personalized health and wellness insights.
About GeneAI Forecast
GeneAI Forecast is a service capable of assessing an individual's disease risks based on genomic AI. Covering a wide range from lifestyle-related risks, chronic diseases, progressive diseases, to cancer risks, it addresses a total of 15 diseases through Genesis CONNECT and WGS CONNECT subscription plans.
Lifestyle-Related Risks:
- Hypertension
- Type 2 Diabetes
- Myocardial Infarction
- Stroke
- Chronic Kidney Disease
Chronic Diseases:
- Irritable Bowel Syndrome (IBS) (New)
- Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (New)
Progressive Diseases:
- Osteoarthritis (New)
- Osteoporosis (New)
Cancer Risks:
- Lung Cancer
- Stomach Cancer
It All Starts with DNA Data
GeneAI Forecast is built upon the foundation of DNA data and key biomarkers, forming a health and wellness baseline optimized for each individual. Based on this foundation, the AI continuously refines its risk predictions, evolving beyond static reports into a continuously advancing system that enables earlier and clearer understanding of health risks.
Expanding the Scope of Predictability
In this update, four new predictive models have been added: Irritable Bowel Syndrome (IBS), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Osteoarthritis, and Osteoporosis. These are diseases that often progress gradually with almost no initial symptoms. With a total of 15 models, GeneAI Forecast provides insights for early understanding of potential health risks at a stage where interventions are highly effective.
Integrating Biology and Behavior
GeneAI Forecast has already integrated multiple biomarkers, including key health indicators such as BMI, blood pressure, and blood glucose levels, adding crucial context to DNA data. This update further strengthens the platform's capabilities by capturing real-world behavioral data through integration with Apple Health and Google Fit, directly reflecting activity information like daily step counts into the predictive models. By combining DNA data, biomarkers, and lifestyle information, GeneAI Forecast visualizes personal health risks in a way that continuously evolves over time.
From Prediction to Action
By integrating genetic, biological, and behavioral information, GeneAI Forecast goes beyond mere risk assessment to more clearly indicate the factors influencing an individual's risk profile. This approach helps identify areas for potential intervention, enabling more informed and proactive healthcare decision-making.
Moving Toward a More Proactive Health Model
Michel Mommejat, Representative Director of Genesis Healthcare Co., stated: 'It all starts with DNA data. It is the foundation for understanding personal health and wellness. GeneAI Forecast is built upon this foundation by combining genetic insights, biomarkers, and real-life behavioral data. This allows us to provide more accurate and meaningful predictions, helping individuals discover concrete actions to manage their risks. This is a vital step toward a more proactive, personalized preventive healthcare model.'
To date, Genesis Healthcare has conducted over 2.9 million genetic tests and is building one of the largest genomic datasets in Japan and Asia. GeneAI Forecast represents a shift from static information to continuous, context-based intelligence, supporting long-term, proactive health management.
About Genesis Healthcare Co.
Genesis Healthcare Co. (English company name: A.D.A.M. Innovations Co.) is a pioneer in genomics, AI, and precision health solutions. The company develops cutting-edge technologies across a wide range of genetic fields, including clinical diagnostics, AI-driven R&D data platforms, and consumer genetic testing services. They have conducted over 2.9 million genetic tests and possess the largest R&D genomic database regarding the Japanese population.
About GeneLife
GeneLife is Genesis Healthcare's genetic testing service brand for general consumers. Providing genetic testing services to individuals through at-home test kits and e-commerce channels, it helps people achieve better lives and longevity through personalized health and wellness insights.
About GeneAI Forecast
GeneAI Forecast is a service capable of assessing an individual's disease risks based on genomic AI. Covering a wide range from lifestyle-related risks, chronic diseases, progressive diseases, to cancer risks, it addresses a total of 15 diseases through Genesis CONNECT and WGS CONNECT subscription plans.
Lifestyle-Related Risks:
- Hypertension
- Type 2 Diabetes
- Myocardial Infarction
- Stroke
- Chronic Kidney Disease
Chronic Diseases:
- Irritable Bowel Syndrome (IBS) (New)
- Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (New)
Progressive Diseases:
- Osteoarthritis (New)
- Osteoporosis (New)
Cancer Risks:
- Lung Cancer
- Stomach Cancer